Specialized Hydrocortisone Formulations for Extreme Environments and High-Security Needs
Legal Citation
Summary of the Inventive Concept
Adapted hydrocortisone formulations for disaster relief, high-security, and extreme weather conditions, providing targeted solutions for unique operational environments
Background and Problem Solved
The original patent described an aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol. However, these formulations may not be suitable for extreme environments or high-security needs. The inventive concept addresses this limitation by adapting the formulation for disaster relief, high-security environments, and extreme weather conditions.
Detailed Description of the Inventive Concept
The inventive concept comprises adapted aqueous pharmaceutical formulations of hydrocortisone sodium phosphate and monothioglycerol, packaged in portable, waterproof containers or secure, tamper-evident containers for high-security environments. The formulations are sterilized and designed for use in extreme temperatures, making them suitable for disaster relief and emergency response situations. The inventive concept also includes a pharmaceutical kit for emergency responders, a portable, handheld device for administering the formulation, and a system for remote medical treatment via telemedicine.
Novelty and Inventive Step
The new claims provide a novel and non-obvious adaptation of the original formulation, addressing the specific needs of extreme environments and high-security situations. The inventive step lies in the combination of the original formulation with specialized packaging, sterilization, and delivery systems tailored to these unique operational environments.
Alternative Embodiments and Variations
Alternative embodiments may include adapting the formulation for use in space exploration, search and rescue operations, or other extreme environments. Variations may include different packaging materials, sterilization methods, or delivery systems to further tailor the formulation to specific needs.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical, disaster relief, and high-security industries. Target markets may include government agencies, emergency responders, and private companies operating in extreme environments.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulations, specifically aqueous steroid preparations with stabilizing agents, requiring expertise in pharmaceutical chemistry, drug delivery systems, and medical device engineering
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical chemist or formulation specialist with advanced degree, experience in steroid drug development, knowledge of packaging technologies, and understanding of emergency medical delivery systems
Obviousness Rationale
A PHOSITA would recognize that adapting the hydrocortisone sodium phosphate formulation for specialized environments represents predictable variations using known pharmaceutical engineering techniques. The core chemical composition remains substantially unchanged, with modifications focusing on packaging, delivery method, and contextual application. These adaptations represent standard design choices within pharmaceutical product development that would be apparent to a skilled practitioner.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,555 |
|---|---|
| Title | Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol |
| Assignee(s) | Antares Pharma, Inc. |